Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank92
3Y CAGR-29.7%
5Y CAGR+67.0%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-29.7%/yr
vs +433.3%/yr prior
5Y CAGR
+67.0%/yr
Recent deceleration
Acceleration
-463.0pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
13x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 6.63 | +272.9% |
| 2024 | -3.84 | -12.6% |
| 2023 | -3.41 | -117.9% |
| 2022 | 19.08 | +937.9% |
| 2021 | 1.84 | +260.4% |
| 2020 | 0.51 | +85.9% |
| 2019 | 0.27 | +1063.3% |
| 2018 | 0.02 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |